Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:989

Retinitis Global Clinical Trials Review, Q1, 2011


Retinitis Global Clinical Trials Review, Q1, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description No
Publisher GlobalData
Date of Report Jan 31, 2011
Quick Overview
Retinitis Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, “Retinitis Global Clinical Trials Review, Q1, 2011 provides data on the Retinitis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Retinitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents




...